Medication-Associated (MA) Module
On This Page
The Medication—associated Module consists of one option: the Antimicrobial Use and Resistance option (AUR). Previous studies have shown that feedback of rates of antimicrobial use and resistance to clinicians can improve the appropriateness of antimicrobial prescription. Use of the AUR Option will assist hospitals in collecting data on antimicrobial resistance and/or antimicrobial use so that this information can be used for prevention purposes. All data are collected for all three of the following: 1) at least one intensive care unit or specialty care area (ICU/SCA exclusive of pediatric locations), 2) all non-ICU/SCA areas combined, and 3) all outpatient areas combined.
EXCEPTION: No pharmacy data are collected on outpatient areas.
The AUR Option does not collect data on healthcare-associated infections.
Corresponding Materials
Protocol and Instructions
- Antimicrobial Use and Resistance (AUR) Option PDF (54 KB / 4 pages)
Guidelines and procedures for monitoring AUR. March 2009 - Tables of Instructions Updated June 2009, PDF (422 KB / 49 pages)
Instructions for completing forms
Training
Forms
- 57.106 Patient Safety Monthly Reporting Plan PDF (27 KB / 2 pages)
- 57.123 Antimicrobial Use and Resistance (AUR) Microbiology Laboratory Data - Monthly Report PDF (122 KB /1 page)
- 57.124 Antimicrobial Use and Resistance (AUR) Pharmacy Data - Monthly Report PDF ( 91 KB /1 page)
Get email updates
To receive email updates about NHSN, enter your email address:
Contact NHSN:
-
Centers for Disease Control and Prevention
National Healthcare Safety Network
MS-A24
1600 Clifton Rd
Atlanta, GA 30333 - nhsn@cdc.gov

